FDA Approves Frontline Darzalex/Rd in Transplant-Ineligible Myeloma - Curetoday.com
FDA Approves Frontline Darzalex/Rd in Transplant-Ineligible Myeloma Curetoday.com
The FDA has approved the combination of Darzalex with Revlimid and dexamethasone (DRd) for the treatment of patients with newly diagnosed multiple ...
Comments
Post a Comment